Partners

Ulysses Neuroscience

Lead Partner

Ulysses Neuroscience Ltd is a patient-centric private R&D organization working together with pharmaceutical companies in order to accelerate drug discovery in neuropsychiatric (major depression, anorexia nervosa and schizophrenia) and neurodevelopmental (Fragile X Syndrome and CDKL5 Deficiency Disorders) diseases by using translation clinical and pre-clinical research. Our translational research investigates neurophysiological and molecular mechanisms leading to the synaptic pathology, microtubule dynamics dysregulation and neuroinflammatory events.

ulysses-neuro.ie

Genomenon Logo 2021 - stacked tag (1) (002)

Genomenon

Exhibition Partner

Genomenon's AI-driven Genomic Landscapes deliver a profound understanding of the genetic drivers and clinical attributes of any genetic disease, from neurodegenerative and rare diseases to cancer. This data enables Pharma to accelerate target discovery, identify genetic biomarkers for better clinical trial stratification, and develop CDx for regulatory approval.

www.genomenon.com